JP Morgan Raises PT on Covance To $60

July 29, 2011 6:10 AM | 7 seconds read |
JP Morgan has raised the price target on Covance CVD from $55 to $60 and maintains its Overweight rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst RatingsHealth CareJP MorganLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!